# Silo Pharma, Inc.: Form 8-K, filed Jul 10, 2025

- Company: [Silo Pharma, Inc.](/companies/silo.md) (CIK 1514183)
- Form: 8-K
- Filed: 2025-07-10
- Accepted by EDGAR: Jul 10, 2025, 16:30 ET
- Period: 2025-07-08
- Accession: 0001213900-25-062805
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1514183/000121390025062805/ea0248611-8k_silo.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1514183/000121390025062805/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1514183/000121390025062805/ea0248611-8k_silo.htm

Filed Jul 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-062805. Last ingested by Listed: Nov 6, 2026, 18:16 ET. No prices; not investment advice.
